Leukemia inhibitory factor is an anti-inflammatory and analgesic cytokine

The mRNA for leukemia inhibitory factor (LIF), a neuroimmune signaling molecule, is elevated during skin inflammation produced by intraplantar injection of complete Freund's adjuvant (CFA). Moreover, although LIF knock-out mice display normal sensitivity to cutaneous mechanical and thermal stimulation compared with wild-type mice, the degree of CFA-induced inflammation in mice lacking LIF is enhanced in spatial extent, amplitude, cellular infiltrate, and interleukin (IL)-1 beta and nerve growth factor (NGF) expression. Conversely, local injection of low doses of recombinant LIF diminishes mechanical and thermal hypersensitivity as well as the IL-1 beta and NGF expression induced by CFA. These data show that upregulation of LIF during peripheral inflammation serves a key, early antiinflammatory role and that exogenous LIF can reduce inflammatory hyperalgesia.